Cologne, Germany

Luca Perabo

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 32(Granted Patents)


Location History:

  • Cologne, DE (2017 - 2020)
  • Berlin, DE (2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Luca Perabo

Introduction

Luca Perabo is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of viral capsid proteins and their applications in drug delivery systems. With a total of 4 patents, his work has the potential to impact various medical and therapeutic areas.

Latest Patents

Luca Perabo's latest patents include innovative technologies such as mutated adeno-associated viral capsid proteins for chemical coupling of ligands, nanoparticles, or drugs via thioether binding. This invention focuses on a mutated adeno-associated virus (AAV) capsid protein that allows for specific modifications, enhancing the potential for targeted drug delivery. Another significant patent involves a structural protein of a parvovirus with an amino acid insertion, which opens new avenues for therapeutic applications and the development of medicaments.

Career Highlights

Throughout his career, Luca Perabo has worked with prominent organizations such as Medigene AG and Ludwig-Maximilians-Universität. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Luca has collaborated with notable colleagues, including Hildegard Buening and John Nieland. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of scientific knowledge.

Conclusion

Luca Perabo's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…